Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
This study has been completed.
Study NCT00320775   Information provided by Regeneron Pharmaceuticals

First Received on April 28, 2006.   Last Updated on June 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
Additional conditions recognized in this trial
Wet Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
VEGF Trap
Sponsors listed in this trial
Regeneron Pharmaceuticals
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services